SEC Info - Nymox Pharmaceutical Corp - ‘20-F’ for 12/31/18

SEC Info℠

Home

Help

Please Sign In

Nymox Pharmaceutical Corp – ‘20-F’ for 12/31/18 – ‘EX-101.CAL’

On: Friday, 3/29/19, at 5:20pm ET · For: 12/31/18 · Accession #: 1640334-19-464 · File #: 1-12033

  As Of               Filer                 Filing    For·On·As Docs:Size             Issuer                      Filing Agent

 3/29/19  Nymox Pharmaceutical Corp         20-F       12/31/18  107:5.1M                                   Pubco Reporting … Inc/FA

Annual Report by a Foreign Non-Canadian Issuer — Form 20-F — Sect. 13 / 15(d) – SEA’34
Filing Table of Contents

Document/Exhibit                   Description                      Pages   Size 

 1: 20-F        Annual Report by a Foreign Non-Canadian Issuer      HTML    837K 
 4: EX-13.A     Annual or Quarterly Report to Security Holders      HTML     24K 
 5: EX-13.B     Annual or Quarterly Report to Security Holders      HTML     25K 
 2: EX-12.A     Statement re: Computation of Ratios                 HTML     30K 
 3: EX-12.B     Statement re: Computation of Ratios                 HTML     30K 
12: R1          Document and Entity Information                     HTML     58K 
13: R2          Consolidated Statements of Financial Position       HTML     86K 
14: R3          Consolidated Statements of Financial Position       HTML     27K 
                (Parenthetical)                                                  
15: R4          Consolidated Statements of Comprehensive Income     HTML     76K 
16: R5          Consolidated Statements of Changes in Equity        HTML     69K 
17: R6          Consolidated Statements of Cash Flow                HTML     90K 
18: R7          Business Activities and Basis of Presentation       HTML     36K 
19: R8          Going Concern Considerations                        HTML     29K 
20: R9          Significant Estimates                               HTML     27K 
21: R10         Significant Accounting Policies                     HTML     70K 
22: R11         New Accounting Standards and Interpretations        HTML     38K 
23: R12         Property and Equipment                              HTML     88K 
24: R13         Intangible Assets                                   HTML     28K 
25: R14         Accounts Payable and Accrued Liabilities            HTML     38K 
26: R15         Convertible Notes                                   HTML     39K 
27: R16         Commitments and Contingencies                       HTML     44K 
28: R17         Share Capital                                       HTML     40K 
29: R18         Stock Options                                       HTML     50K 
30: R19         Share Based Compensation                            HTML     36K 
31: R20         Warrants                                            HTML     58K 
32: R21         Income Taxes                                        HTML     75K 
33: R22         Earnings Per Share                                  HTML     34K 
34: R23         Financial Instruments Fair Value Disclosures        HTML     28K 
35: R24         Finance Income and Finance Costs                    HTML     48K 
36: R25         Segment Disclosures                                 HTML     43K 
37: R26         Concentrations                                      HTML     31K 
38: R27         Related Party Transactions                          HTML     39K 
39: R28         Research and Development Expenses                   HTML     39K 
40: R29         Personnel Expenses                                  HTML     36K 
41: R30         Capital Disclosures and Financial Risk              HTML     29K 
42: R31         Foreign Exchange Risk                               HTML     28K 
43: R32         Credit Risk                                         HTML     30K 
44: R33         27. Interest Rate Risk                              HTML     27K 
45: R34         28. Liquidity Risk                                  HTML     40K 
46: R35         29. Subsequent Events                               HTML     28K 
47: R36         Significant Accounting Policies (Policies)          HTML    121K 
48: R37         Significant Accounting Policies (Tables)            HTML     29K 
49: R38         Property and Equipment (Tables)                     HTML     87K 
50: R39         Accounts Payable and Accrued Liabilities (Tables)   HTML     36K 
51: R40         Convertible Notes (Tables)                          HTML     35K 
52: R41         Commitments and Contingencies (Tables)              HTML     43K 
53: R42         Share Capital (Tables)                              HTML     36K 
54: R43         Stock Options (Tables)                              HTML     55K 
55: R44         Share Based Compensation (Tables)                   HTML     33K 
56: R45         Warrants (Tables)                                   HTML     55K 
57: R46         Income Taxes (Tables)                               HTML     74K 
58: R47         Earnings Per Share (Tables)                         HTML     33K 
59: R48         Finance Income and Finance Costs (Tables)           HTML     47K 
60: R49         Segment Disclosures (Tables)                        HTML     42K 
61: R50         Concentrations (Tables)                             HTML     31K 
62: R51         Related Party Transactions (Tables)                 HTML     35K 
63: R52         Research and Development Expenses (Tables)          HTML     38K 
64: R53         Personnel Expenses (Tables)                         HTML     36K 
65: R54         Liquidity risk (Tables)                             HTML     38K 
66: R55         Significant Accounting Policies (Details)           HTML     33K 
67: R56         Property and Equipment (Details)                    HTML     61K 
68: R57         Property and Equipment (Details Narrative)          HTML     28K 
69: R58         Intangible Assets (Details Narrative)               HTML     37K 
70: R59         Accounts Payable and Accrued Liabilities (Details)  HTML     33K 
71: R60         Convertible Notes (Details)                         HTML     31K 
72: R61         Convertible Notes (Details Narrative)               HTML     39K 
73: R62         Commitments and Contingencies (Details)             HTML     36K 
74: R63         Commitments and Contingencies (Details 1)           HTML     33K 
75: R64         Commitments and Contingencies (Details 2)           HTML     35K 
76: R65         Commitments and Contingencies (Details Narrative)   HTML     38K 
77: R66         Share Capital (Details)                             HTML     29K 
78: R67         Share Capital (Details Narrative)                   HTML     38K 
79: R68         Stock Options (Details)                             HTML     50K 
80: R69         Stock Options (Details 1)                           HTML     43K 
81: R70         Stock Options (Details Narrative)                   HTML     29K 
82: R71         Share Based Compensation (Details)                  HTML     34K 
83: R72         Share Based Compensation (Details Narrative)        HTML     37K 
84: R73         Warrants (Details)                                  HTML     45K 
85: R74         Warrants (Details Narrative)                        HTML     35K 
86: R75         Income Taxes (Details)                              HTML     44K 
87: R76         Income Taxes (Details 1)                            HTML     32K 
88: R77         Income Taxes (Details 2)                            HTML     83K 
89: R78         Income Taxes (Details Narrative)                    HTML     28K 
90: R79         Earnings Per Share (Details)                        HTML     31K 
91: R80         Financial Instruments Fair Value Disclosures        HTML     26K 
                (Details Narrative)                                              
92: R81         Finance Income and Finance Costs (Details)          HTML     46K 
93: R82         Segment Disclosures (Details)                       HTML     43K 
94: R83         Concentrations (Details)                            HTML     32K 
95: R84         Related Party Transactions (Details)                HTML     37K 
96: R85         Related Party Transactions (Details Narrative)      HTML     36K 
97: R86         Research and Development Expenses (Details)         HTML     40K 
98: R87         Personnel Expenses (Details)                        HTML     36K 
99: R88         Capital Disclosures and Financial Risk (Details     HTML     41K 
                Narrative)                                                       
100: R89         Foreign Exchange risk (Details Narrative)           HTML     27K  
101: R90         Credit risk (Details Narrative)                     HTML     33K  
102: R91         Interest rate risk (Details Narrative)              HTML     26K  
103: R92         Liquidity risk (Details)                            HTML     37K  
104: R93         Subsequent Events (Details Narrative)               HTML     39K  
106: XML         IDEA XML File -- Filing Summary                      XML    195K  
105: EXCEL       IDEA Workbook of Financial Reports                  XLSX    100K  
 6: EX-101.INS  XBRL Instance -- nymx-20181231                       XML   1.72M 
 8: EX-101.CAL  XBRL Calculations -- nymx-20181231_cal               XML    142K 
 9: EX-101.DEF  XBRL Definitions -- nymx-20181231_def                XML    469K 
10: EX-101.LAB  XBRL Labels -- nymx-20181231_lab                     XML    895K 
11: EX-101.PRE  XBRL Presentations -- nymx-20181231_pre              XML    742K 
 7: EX-101.SCH  XBRL Schema -- nymx-20181231                         XSD    294K 
107: ZIP         XBRL Zipped Folder -- 0001640334-19-000464-xbrl      Zip    132K

‘EX-101.CAL’ — XBRL Calculations — nymx-20181231_cal

This Exhibit is an XBRL XML File.

<?xml version="1.0" standalone="no" encoding="windows-1252"?>

<link:linkbase xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xbrli="http://www.xbrl.org/2003/instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">

<link:roleRef roleURI="http://nymox.com/role/DocumentAndEntityInformation" xlink:href="nymx-20181231.xsd#DocumentAndEntityInformation" xlink:type="simple"/>

<link:roleRef roleURI="http://nymox.com/role/StatementsOfFinancialPosition" xlink:href="nymx-20181231.xsd#StatementsOfFinancialPosition" xlink:type="simple"/>

<link:roleRef roleURI="http://nymox.com/role/StatementsOfFinancialPositionParenthetical" xlink:href="nymx-20181231.xsd#StatementsOfFinancialPositionParenthetical" xlink:type="simple"/>

<link:roleRef roleURI="http://nymox.com/role/StatementsOfComprehensiveIncome" xlink:href="nymx-20181231.xsd#StatementsOfComprehensiveIncome" xlink:type="simple"/>

<link:roleRef roleURI="http://nymox.com/role/StatementsOfChangesInEquity" xlink:href="nymx-20181231.xsd#StatementsOfChangesInEquity" xlink:type="simple"/>

<link:roleRef roleURI="http://nymox.com/role/StatementsOfCashFlow" xlink:href="nymx-20181231.xsd#StatementsOfCashFlow" xlink:type="simple"/>

<link:roleRef roleURI="http://nymox.com/role/BusinessActivitiesAndBasisOfPresentation" xlink:href="nymx-20181231.xsd#BusinessActivitiesAndBasisOfPresentation" xlink:type="simple"/>

<link:roleRef roleURI="http://nymox.com/role/GoingConcernConsiderations" xlink:href="nymx-20181231.xsd#GoingConcernConsiderations" xlink:type="simple"/>

<link:roleRef roleURI="http://nymox.com/role/SignificantEstimates" xlink:href="nymx-20181231.xsd#SignificantEstimates" xlink:type="simple"/>

<link:roleRef roleURI="http://nymox.com/role/SignificantAccountingPolicies" xlink:href="nymx-20181231.xsd#SignificantAccountingPolicies" xlink:type="simple"/>

<link:roleRef roleURI="http://nymox.com/role/NewAccountingStandardsAndInterpretations" xlink:href="nymx-20181231.xsd#NewAccountingStandardsAndInterpretations" xlink:type="simple"/>

<link:roleRef roleURI="http://nymox.com/role/PropertyAndEquipment" xlink:href="nymx-20181231.xsd#PropertyAndEquipment" xlink:type="simple"/>

<link:roleRef roleURI="http://nymox.com/role/IntangibleAssets" xlink:href="nymx-20181231.xsd#IntangibleAssets" xlink:type="simple"/>

<link:roleRef roleURI="http://nymox.com/role/AccountsPayableAndAccruedLiabilities" xlink:href="nymx-20181231.xsd#AccountsPayableAndAccruedLiabilities" xlink:type="simple"/>

<link:roleRef roleURI="http://nymox.com/role/ConvertibleNotes" xlink:href="nymx-20181231.xsd#ConvertibleNotes" xlink:type="simple"/>

<link:roleRef roleURI="http://nymox.com/role/CommitmentsAndContingencies" xlink:href="nymx-20181231.xsd#CommitmentsAndContingencies" xlink:type="simple"/>

<link:roleRef roleURI="http://nymox.com/role/ShareCapital" xlink:href="nymx-20181231.xsd#ShareCapital" xlink:type="simple"/>

<link:roleRef roleURI="http://nymox.com/role/StockOptions" xlink:href="nymx-20181231.xsd#StockOptions" xlink:type="simple"/>

<link:roleRef roleURI="http://nymox.com/role/ShareBasedCompensation" xlink:href="nymx-20181231.xsd#ShareBasedCompensation" xlink:type="simple"/>

<link:roleRef roleURI="http://nymox.com/role/Warrants" xlink:href="nymx-20181231.xsd#Warrants" xlink:type="simple"/>

<link:roleRef roleURI="http://nymox.com/role/IncomeTaxes" xlink:href="nymx-20181231.xsd#IncomeTaxes" xlink:type="simple"/>

<link:roleRef roleURI="http://nymox.com/role/EarningsPerShare" xlink:href="nymx-20181231.xsd#EarningsPerShare" xlink:type="simple"/>

<link:roleRef roleURI="http://nymox.com/role/FinancialInstrumentsFairValueDisclosures" xlink:href="nymx-20181231.xsd#FinancialInstrumentsFairValueDisclosures" xlink:type="simple"/>

<link:roleRef roleURI="http://nymox.com/role/FinanceIncomeAndFinanceCosts" xlink:href="nymx-20181231.xsd#FinanceIncomeAndFinanceCosts" xlink:type="simple"/>

<link:roleRef roleURI="http://nymox.com/role/SegmentDisclosures" xlink:href="nymx-20181231.xsd#SegmentDisclosures" xlink:type="simple"/>

<link:roleRef roleURI="http://nymox.com/role/Concentrations" xlink:href="nymx-20181231.xsd#Concentrations" xlink:type="simple"/>

<link:roleRef roleURI="http://nymox.com/role/RelatedPartyTransactions" xlink:href="nymx-20181231.xsd#RelatedPartyTransactions" xlink:type="simple"/>

<link:roleRef roleURI="http://nymox.com/role/ResearchAndDevelopmentExpenses" xlink:href="nymx-20181231.xsd#ResearchAndDevelopmentExpenses" xlink:type="simple"/>

<link:roleRef roleURI="http://nymox.com/role/PersonnelExpenses" xlink:href="nymx-20181231.xsd#PersonnelExpenses" xlink:type="simple"/>

<link:roleRef roleURI="http://nymox.com/role/CapitalDisclosuresAndFinancialRisk" xlink:href="nymx-20181231.xsd#CapitalDisclosuresAndFinancialRisk" xlink:type="simple"/>

<link:roleRef roleURI="http://nymox.com/role/ForeignExchangeRisk" xlink:href="nymx-20181231.xsd#ForeignExchangeRisk" xlink:type="simple"/>

<link:roleRef roleURI="http://nymox.com/role/CreditRisk" xlink:href="nymx-20181231.xsd#CreditRisk" xlink:type="simple"/>

<link:roleRef roleURI="http://nymox.com/role/InterestRateRisk" xlink:href="nymx-20181231.xsd#InterestRateRisk" xlink:type="simple"/>

<link:roleRef roleURI="http://nymox.com/role/LiquidityRisk" xlink:href="nymx-20181231.xsd#LiquidityRisk" xlink:type="simple"/>

<link:roleRef roleURI="http://nymox.com/role/SubsequentEvents" xlink:href="nymx-20181231.xsd#SubsequentEvents" xlink:type="simple"/>

<link:roleRef roleURI="http://nymox.com/role/SignificantAccountingPoliciesPolicies" xlink:href="nymx-20181231.xsd#SignificantAccountingPoliciesPolicies" xlink:type="simple"/>

<link:roleRef roleURI="http://nymox.com/role/SignificantAccountingPoliciesTables" xlink:href="nymx-20181231.xsd#SignificantAccountingPoliciesTables" xlink:type="simple"/>

<link:roleRef roleURI="http://nymox.com/role/PropertyAndEquipmentTables" xlink:href="nymx-20181231.xsd#PropertyAndEquipmentTables" xlink:type="simple"/>

<link:roleRef roleURI="http://nymox.com/role/AccountsPayableAndAccruedLiabilitiesTables" xlink:href="nymx-20181231.xsd#AccountsPayableAndAccruedLiabilitiesTables" xlink:type="simple"/>

<link:roleRef roleURI="http://nymox.com/role/ConvertibleNotesTables" xlink:href="nymx-20181231.xsd#ConvertibleNotesTables" xlink:type="simple"/>

<link:roleRef roleURI="http://nymox.com/role/CommitmentsAndContingenciesTables" xlink:href="nymx-20181231.xsd#CommitmentsAndContingenciesTables" xlink:type="simple"/>

<link:roleRef roleURI="http://nymox.com/role/ShareCapitalTables" xlink:href="nymx-20181231.xsd#ShareCapitalTables" xlink:type="simple"/>

<link:roleRef roleURI="http://nymox.com/role/StockOptionsTables" xlink:href="nymx-20181231.xsd#StockOptionsTables" xlink:type="simple"/>

<link:roleRef roleURI="http://nymox.com/role/ShareBasedCompensationTables" xlink:href="nymx-20181231.xsd#ShareBasedCompensationTables" xlink:type="simple"/>

<link:roleRef roleURI="http://nymox.com/role/WarrantsTables" xlink:href="nymx-20181231.xsd#WarrantsTables" xlink:type="simple"/>

<link:roleRef roleURI="http://nymox.com/role/IncomeTaxesTables" xlink:href="nymx-20181231.xsd#IncomeTaxesTables" xlink:type="simple"/>

<link:roleRef roleURI="http://nymox.com/role/EarningsPerShareTables" xlink:href="nymx-20181231.xsd#EarningsPerShareTables" xlink:type="simple"/>

<link:roleRef roleURI="http://nymox.com/role/FinanceIncomeAndFinanceCostsTables" xlink:href="nymx-20181231.xsd#FinanceIncomeAndFinanceCostsTables" xlink:type="simple"/>

<link:roleRef roleURI="http://nymox.com/role/SegmentDisclosuresTables" xlink:href="nymx-20181231.xsd#SegmentDisclosuresTables" xlink:type="simple"/>

<link:roleRef roleURI="http://nymox.com/role/ConcentrationsTables" xlink:href="nymx-20181231.xsd#ConcentrationsTables" xlink:type="simple"/>

<link:roleRef roleURI="http://nymox.com/role/RelatedPartyTransactionsTables" xlink:href="nymx-20181231.xsd#RelatedPartyTransactionsTables" xlink:type="simple"/>

<link:roleRef roleURI="http://nymox.com/role/ResearchAndDevelopmentExpensesTables" xlink:href="nymx-20181231.xsd#ResearchAndDevelopmentExpensesTables" xlink:type="simple"/>

<link:roleRef roleURI="http://nymox.com/role/PersonnelExpensesTables" xlink:href="nymx-20181231.xsd#PersonnelExpensesTables" xlink:type="simple"/>

<link:roleRef roleURI="http://nymox.com/role/LiquidityRiskTables" xlink:href="nymx-20181231.xsd#LiquidityRiskTables" xlink:type="simple"/>

<link:roleRef roleURI="http://nymox.com/role/SignificantAccountingPoliciesDetails" xlink:href="nymx-20181231.xsd#SignificantAccountingPoliciesDetails" xlink:type="simple"/>

<link:roleRef roleURI="http://nymox.com/role/PropertyAndEquipmentDetails" xlink:href="nymx-20181231.xsd#PropertyAndEquipmentDetails" xlink:type="simple"/>

<link:roleRef roleURI="http://nymox.com/role/PropertyAndEquipmentDetailsNarrative" xlink:href="nymx-20181231.xsd#PropertyAndEquipmentDetailsNarrative" xlink:type="simple"/>

<link:roleRef roleURI="http://nymox.com/role/IntangibleAssetsDetailsNarrative" xlink:href="nymx-20181231.xsd#IntangibleAssetsDetailsNarrative" xlink:type="simple"/>

<link:roleRef roleURI="http://nymox.com/role/AccountsPayableAndAccruedLiabilitiesDetails" xlink:href="nymx-20181231.xsd#AccountsPayableAndAccruedLiabilitiesDetails" xlink:type="simple"/>

<link:roleRef roleURI="http://nymox.com/role/ConvertibleNotesDetails" xlink:href="nymx-20181231.xsd#ConvertibleNotesDetails" xlink:type="simple"/>

<link:roleRef roleURI="http://nymox.com/role/ConvertibleNotesDetailsNarrative" xlink:href="nymx-20181231.xsd#ConvertibleNotesDetailsNarrative" xlink:type="simple"/>

<link:roleRef roleURI="http://nymox.com/role/CommitmentsAndContingenciesDetails" xlink:href="nymx-20181231.xsd#CommitmentsAndContingenciesDetails" xlink:type="simple"/>

<link:roleRef roleURI="http://nymox.com/role/CommitmentsAndContingenciesDetails1" xlink:href="nymx-20181231.xsd#CommitmentsAndContingenciesDetails1" xlink:type="simple"/>

<link:roleRef roleURI="http://nymox.com/role/CommitmentsAndContingenciesDetails2" xlink:href="nymx-20181231.xsd#CommitmentsAndContingenciesDetails2" xlink:type="simple"/>

<link:roleRef roleURI="http://nymox.com/role/CommitmentsAndContingenciesDetailsNarrative" xlink:href="nymx-20181231.xsd#CommitmentsAndContingenciesDetailsNarrative" xlink:type="simple"/>

<link:roleRef roleURI="http://nymox.com/role/ShareCapitalDetails" xlink:href="nymx-20181231.xsd#ShareCapitalDetails" xlink:type="simple"/>

<link:roleRef roleURI="http://nymox.com/role/ShareCapitalDetailsNarrative" xlink:href="nymx-20181231.xsd#ShareCapitalDetailsNarrative" xlink:type="simple"/>

<link:roleRef roleURI="http://nymox.com/role/StockOptionsDetails" xlink:href="nymx-20181231.xsd#StockOptionsDetails" xlink:type="simple"/>

<link:roleRef roleURI="http://nymox.com/role/StockOptionsDetails1" xlink:href="nymx-20181231.xsd#StockOptionsDetails1" xlink:type="simple"/>

<link:roleRef roleURI="http://nymox.com/role/StockOptionsDetailsNarrative" xlink:href="nymx-20181231.xsd#StockOptionsDetailsNarrative" xlink:type="simple"/>

<link:roleRef roleURI="http://nymox.com/role/ShareBasedCompensationDetails" xlink:href="nymx-20181231.xsd#ShareBasedCompensationDetails" xlink:type="simple"/>

<link:roleRef roleURI="http://nymox.com/role/ShareBasedCompensationDetailsNarrative" xlink:href="nymx-20181231.xsd#ShareBasedCompensationDetailsNarrative" xlink:type="simple"/>

<link:roleRef roleURI="http://nymox.com/role/WarrantsDetails" xlink:href="nymx-20181231.xsd#WarrantsDetails" xlink:type="simple"/>

<link:roleRef roleURI="http://nymox.com/role/WarrantsDetailsNarrative" xlink:href="nymx-20181231.xsd#WarrantsDetailsNarrative" xlink:type="simple"/>

<link:roleRef roleURI="http://nymox.com/role/IncomeTaxesDetails" xlink:href="nymx-20181231.xsd#IncomeTaxesDetails" xlink:type="simple"/>

<link:roleRef roleURI="http://nymox.com/role/IncomeTaxesDetails1" xlink:href="nymx-20181231.xsd#IncomeTaxesDetails1" xlink:type="simple"/>

<link:roleRef roleURI="http://nymox.com/role/IncomeTaxesDetails2" xlink:href="nymx-20181231.xsd#IncomeTaxesDetails2" xlink:type="simple"/>

<link:roleRef roleURI="http://nymox.com/role/IncomeTaxesDetailsNarrative" xlink:href="nymx-20181231.xsd#IncomeTaxesDetailsNarrative" xlink:type="simple"/>

<link:roleRef roleURI="http://nymox.com/role/EarningsPerShareDetails" xlink:href="nymx-20181231.xsd#EarningsPerShareDetails" xlink:type="simple"/>

<link:roleRef roleURI="http://nymox.com/role/FinancialInstrumentsFairValueDisclosuresDetailsNarrative" xlink:href="nymx-20181231.xsd#FinancialInstrumentsFairValueDisclosuresDetailsNarrative" xlink:type="simple"/>

<link:roleRef roleURI="http://nymox.com/role/FinanceIncomeAndFinanceCostsDetails" xlink:href="nymx-20181231.xsd#FinanceIncomeAndFinanceCostsDetails" xlink:type="simple"/>

<link:roleRef roleURI="http://nymox.com/role/SegmentDisclosuresDetails" xlink:href="nymx-20181231.xsd#SegmentDisclosuresDetails" xlink:type="simple"/>

<link:roleRef roleURI="http://nymox.com/role/ConcentrationsDetails" xlink:href="nymx-20181231.xsd#ConcentrationsDetails" xlink:type="simple"/>

<link:roleRef roleURI="http://nymox.com/role/RelatedPartyTransactionsDetails" xlink:href="nymx-20181231.xsd#RelatedPartyTransactionsDetails" xlink:type="simple"/>

<link:roleRef roleURI="http://nymox.com/role/RelatedPartyTransactionsDetailsNarrative" xlink:href="nymx-20181231.xsd#RelatedPartyTransactionsDetailsNarrative" xlink:type="simple"/>

<link:roleRef roleURI="http://nymox.com/role/ResearchAndDevelopmentExpensesDetails" xlink:href="nymx-20181231.xsd#ResearchAndDevelopmentExpensesDetails" xlink:type="simple"/>

<link:roleRef roleURI="http://nymox.com/role/PersonnelExpensesDetails" xlink:href="nymx-20181231.xsd#PersonnelExpensesDetails" xlink:type="simple"/>

<link:roleRef roleURI="http://nymox.com/role/CapitalDisclosuresAndFinancialRiskDetailsNarrative" xlink:href="nymx-20181231.xsd#CapitalDisclosuresAndFinancialRiskDetailsNarrative" xlink:type="simple"/>

<link:roleRef roleURI="http://nymox.com/role/ForeignExchangeRiskDetailsNarrative" xlink:href="nymx-20181231.xsd#ForeignExchangeRiskDetailsNarrative" xlink:type="simple"/>

<link:roleRef roleURI="http://nymox.com/role/CreditRiskDetailsNarrative" xlink:href="nymx-20181231.xsd#CreditRiskDetailsNarrative" xlink:type="simple"/>

<link:roleRef roleURI="http://nymox.com/role/InterestRateRiskDetailsNarrative" xlink:href="nymx-20181231.xsd#InterestRateRiskDetailsNarrative" xlink:type="simple"/>

<link:roleRef roleURI="http://nymox.com/role/LiquidityRiskDetails" xlink:href="nymx-20181231.xsd#LiquidityRiskDetails" xlink:type="simple"/>

<link:roleRef roleURI="http://nymox.com/role/SubsequentEventsDetailsNarrative" xlink:href="nymx-20181231.xsd#SubsequentEventsDetailsNarrative" xlink:type="simple"/>

<link:calculationLink xlink:type="extended" xlink:role="http://nymox.com/role/DocumentAndEntityInformation" xlink:title="00000001 - Document - Document and Entity Information"/>

<link:calculationLink xlink:type="extended" xlink:role="http://nymox.com/role/StatementsOfFinancialPosition" xlink:title="00000002 - Statement - Consolidated Statements of Financial Position">

<link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2018-03-16/full_ifrs/full_ifrs-cor_2018-03-16.xsd#ifrs-full_Assets" xlink:label="loc_ifrs-fullAssets"/>

<link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2018-03-16/full_ifrs/full_ifrs-cor_2018-03-16.xsd#ifrs-full_CurrentAssets" xlink:label="loc_ifrs-fullCurrentAssets"/>

<link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-fullAssets" xlink:to="loc_ifrs-fullCurrentAssets" xlink:type="arc" weight="1"/>

<link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2018-03-16/full_ifrs/full_ifrs-cor_2018-03-16.xsd#ifrs-full_PropertyPlantAndEquipment" xlink:label="loc_ifrs-fullPropertyPlantAndEquipment"/>

<link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-fullAssets" xlink:to="loc_ifrs-fullPropertyPlantAndEquipment" xlink:type="arc" weight="1"/>

<link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2018-03-16/full_ifrs/full_ifrs-cor_2018-03-16.xsd#ifrs-full_OtherAssets" xlink:label="loc_ifrs-fullOtherAssets"/>

<link:calculationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-fullAssets" xlink:to="loc_ifrs-fullOtherAssets" xlink:type="arc" weight="1"/>

<link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2018-03-16/full_ifrs/full_ifrs-cor_2018-03-16.xsd#ifrs-full_Liabilities" xlink:label="loc_ifrs-fullLiabilities"/>

<link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2018-03-16/full_ifrs/full_ifrs-cor_2018-03-16.xsd#ifrs-full_TradeAndOtherCurrentPayables" xlink:label="loc_ifrs-fullTradeAndOtherCurrentPayables"/>

<link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-fullLiabilities" xlink:to="loc_ifrs-fullTradeAndOtherCurrentPayables" xlink:type="arc" weight="1"/>

<link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2018-03-16/full_ifrs/full_ifrs-cor_2018-03-16.xsd#ifrs-full_OtherCurrentFinancialLiabilities" xlink:label="loc_ifrs-fullOtherCurrentFinancialLiabilities"/>

<link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-fullLiabilities" xlink:to="loc_ifrs-fullOtherCurrentFinancialLiabilities" xlink:type="arc" weight="1"/>

<link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2018-03-16/full_ifrs/full_ifrs-cor_2018-03-16.xsd#ifrs-full_EquityAndLiabilities" xlink:label="loc_ifrs-fullEquityAndLiabilities"/>

<link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-fullEquityAndLiabilities" xlink:to="loc_ifrs-fullLiabilities" xlink:type="arc" weight="1"/>

<link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2018-03-16/full_ifrs/full_ifrs-cor_2018-03-16.xsd#ifrs-full_Equity" xlink:label="loc_ifrs-fullEquity"/>

<link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-fullEquityAndLiabilities" xlink:to="loc_ifrs-fullEquity" xlink:type="arc" weight="1"/>

</link:calculationLink>

<link:calculationLink xlink:type="extended" xlink:role="http://nymox.com/role/StatementsOfFinancialPositionParenthetical" xlink:title="00000003 - Statement - Consolidated Statements of Financial Position (Parenthetical)"/>

<link:calculationLink xlink:type="extended" xlink:role="http://nymox.com/role/StatementsOfComprehensiveIncome" xlink:title="00000004 - Statement - Consolidated Statements of Comprehensive Income">

<link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2018-03-16/full_ifrs/full_ifrs-cor_2018-03-16.xsd#ifrs-full_Revenue" xlink:label="loc_ifrs-fullRevenue"/>

<link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2018-03-16/full_ifrs/full_ifrs-cor_2018-03-16.xsd#ifrs-full_RevenueFromSaleOfGoods" xlink:label="loc_ifrs-fullRevenueFromSaleOfGoods"/>

<link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-fullRevenue" xlink:to="loc_ifrs-fullRevenueFromSaleOfGoods" xlink:type="arc" weight="1"/>

<link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2018-03-16/full_ifrs/full_ifrs-cor_2018-03-16.xsd#ifrs-full_OtherRevenue" xlink:label="loc_ifrs-fullOtherRevenue"/>

<link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-fullRevenue" xlink:to="loc_ifrs-fullOtherRevenue" xlink:type="arc" weight="1"/>

<link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2018-03-16/full_ifrs/full_ifrs-cor_2018-03-16.xsd#ifrs-full_ExpenseByNature" xlink:label="loc_ifrs-fullExpenseByNature"/>

<link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2018-03-16/full_ifrs/full_ifrs-cor_2018-03-16.xsd#ifrs-full_ResearchAndDevelopmentExpense" xlink:label="loc_ifrs-fullResearchAndDevelopmentExpense"/>

<link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-fullExpenseByNature" xlink:to="loc_ifrs-fullResearchAndDevelopmentExpense" xlink:type="arc" weight="1"/>

<link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2018-03-16/full_ifrs/full_ifrs-cor_2018-03-16.xsd#ifrs-full_SellingGeneralAndAdministrativeExpense" xlink:label="loc_ifrs-fullSellingGeneralAndAdministrativeExpense"/>

<link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-fullExpenseByNature" xlink:to="loc_ifrs-fullSellingGeneralAndAdministrativeExpense" xlink:type="arc" weight="1"/>

<link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2018-03-16/full_ifrs/full_ifrs-cor_2018-03-16.xsd#ifrs-full_SalesAndMarketingExpense" xlink:label="loc_ifrs-fullSalesAndMarketingExpense"/>

<link:calculationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-fullExpenseByNature" xlink:to="loc_ifrs-fullSalesAndMarketingExpense" xlink:type="arc" weight="1"/>

<link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2018-03-16/full_ifrs/full_ifrs-cor_2018-03-16.xsd#ifrs-full_CostOfSales" xlink:label="loc_ifrs-fullCostOfSales"/>

<link:calculationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-fullExpenseByNature" xlink:to="loc_ifrs-fullCostOfSales" xlink:type="arc" weight="1"/>

<link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2018-03-16/full_ifrs/full_ifrs-cor_2018-03-16.xsd#ifrs-full_ProfitLossFromOperatingActivities" xlink:label="loc_ifrs-fullProfitLossFromOperatingActivities"/>

<link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-fullProfitLossFromOperatingActivities" xlink:to="loc_ifrs-fullRevenue" xlink:type="arc" weight="1"/>

<link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-fullProfitLossFromOperatingActivities" xlink:to="loc_ifrs-fullExpenseByNature" xlink:type="arc" weight="-1"/>

<link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2018-03-16/full_ifrs/full_ifrs-cor_2018-03-16.xsd#ifrs-full_ProfitLossBeforeTax" xlink:label="loc_ifrs-fullProfitLossBeforeTax"/>

<link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-fullProfitLossBeforeTax" xlink:to="loc_ifrs-fullProfitLossFromOperatingActivities" xlink:type="arc" weight="1"/>

<link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2018-03-16/full_ifrs/full_ifrs-cor_2018-03-16.xsd#ifrs-full_FinanceCosts" xlink:label="loc_ifrs-fullFinanceCosts"/>

<link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-fullProfitLossBeforeTax" xlink:to="loc_ifrs-fullFinanceCosts" xlink:type="arc" weight="-1"/>

<link:loc xlink:type="locator" xlink:href="nymx-20181231.xsd#NYMX_InterestIncome" xlink:label="loc_NYMXInterestIncome"/>

<link:calculationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-fullProfitLossBeforeTax" xlink:to="loc_NYMXInterestIncome" xlink:type="arc" weight="1"/>

<link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2018-03-16/full_ifrs/full_ifrs-cor_2018-03-16.xsd#ifrs-full_ProfitLoss" xlink:label="loc_ifrs-fullProfitLoss"/>

<link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-fullProfitLoss" xlink:to="loc_ifrs-fullProfitLossBeforeTax" xlink:type="arc" weight="1"/>

<link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2018-03-16/full_ifrs/full_ifrs-cor_2018-03-16.xsd#ifrs-full_IncomeTaxExpenseContinuingOperations" xlink:label="loc_ifrs-fullIncomeTaxExpenseContinuingOperations"/>

<link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-fullProfitLoss" xlink:to="loc_ifrs-fullIncomeTaxExpenseContinuingOperations" xlink:type="arc" weight="-1"/>

</link:calculationLink>

<link:calculationLink xlink:type="extended" xlink:role="http://nymox.com/role/StatementsOfChangesInEquity" xlink:title="00000005 - Statement - Consolidated Statements of Changes in Equity"/>

<link:calculationLink xlink:type="extended" xlink:role="http://nymox.com/role/StatementsOfCashFlow" xlink:title="00000006 - Statement - Consolidated Statements of Cash Flow">

<link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2018-03-16/full_ifrs/full_ifrs-cor_2018-03-16.xsd#ifrs-full_CashFlowsFromUsedInOperatingActivities" xlink:label="loc_ifrs-fullCashFlowsFromUsedInOperatingActivities"/>

<link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2018-03-16/full_ifrs/full_ifrs-cor_2018-03-16.xsd#ifrs-full_ProfitLoss" xlink:label="loc_ifrs-fullProfitLoss"/>

<link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-fullCashFlowsFromUsedInOperatingActivities" xlink:to="loc_ifrs-fullProfitLoss" xlink:type="arc" weight="1"/>

<link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2018-03-16/full_ifrs/full_ifrs-cor_2018-03-16.xsd#ifrs-full_AdjustmentsForDepreciationExpense" xlink:label="loc_ifrs-fullAdjustmentsForDepreciationExpense"/>

<link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-fullCashFlowsFromUsedInOperatingActivities" xlink:to="loc_ifrs-fullAdjustmentsForDepreciationExpense" xlink:type="arc" weight="1"/>

<link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2018-03-16/full_ifrs/full_ifrs-cor_2018-03-16.xsd#ifrs-full_AdjustmentsForSharebasedPayments" xlink:label="loc_ifrs-fullAdjustmentsForSharebasedPayments"/>

<link:calculationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-fullCashFlowsFromUsedInOperatingActivities" xlink:to="loc_ifrs-fullAdjustmentsForSharebasedPayments" xlink:type="arc" weight="1"/>

<link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2018-03-16/full_ifrs/full_ifrs-cor_2018-03-16.xsd#ifrs-full_AdjustmentsForProvisions" xlink:label="loc_ifrs-fullAdjustmentsForProvisions"/>

<link:calculationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-fullCashFlowsFromUsedInOperatingActivities" xlink:to="loc_ifrs-fullAdjustmentsForProvisions" xlink:type="arc" weight="1"/>

<link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2018-03-16/full_ifrs/full_ifrs-cor_2018-03-16.xsd#ifrs-full_AdjustmentsForDecreaseIncreaseInTradeAndOtherReceivables" xlink:label="loc_ifrs-fullAdjustmentsForDecreaseIncreaseInTradeAndOtherReceivables"/>

<link:calculationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-fullCashFlowsFromUsedInOperatingActivities" xlink:to="loc_ifrs-fullAdjustmentsForDecreaseIncreaseInTradeAndOtherReceivables" xlink:type="arc" weight="1"/>

<link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2018-03-16/full_ifrs/full_ifrs-cor_2018-03-16.xsd#ifrs-full_AdjustmentsForDecreaseIncreaseInOtherAssets" xlink:label="loc_ifrs-fullAdjustmentsForDecreaseIncreaseInOtherAssets"/>

<link:calculationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-fullCashFlowsFromUsedInOperatingActivities" xlink:to="loc_ifrs-fullAdjustmentsForDecreaseIncreaseInOtherAssets" xlink:type="arc" weight="1"/>

<link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2018-03-16/full_ifrs/full_ifrs-cor_2018-03-16.xsd#ifrs-full_AdjustmentsForIncreaseDecreaseInDepositsFromBanks" xlink:label="loc_ifrs-fullAdjustmentsForIncreaseDecreaseInDepositsFromBanks"/>

<link:calculationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-fullCashFlowsFromUsedInOperatingActivities" xlink:to="loc_ifrs-fullAdjustmentsForIncreaseDecreaseInDepositsFromBanks" xlink:type="arc" weight="1"/>

<link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2018-03-16/full_ifrs/full_ifrs-cor_2018-03-16.xsd#ifrs-full_AdjustmentsForIncreaseDecreaseInOtherCurrentLiabilities" xlink:label="loc_ifrs-fullAdjustmentsForIncreaseDecreaseInOtherCurrentLiabilities"/>

<link:calculationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-fullCashFlowsFromUsedInOperatingActivities" xlink:to="loc_ifrs-fullAdjustmentsForIncreaseDecreaseInOtherCurrentLiabilities" xlink:type="arc" weight="1"/>

<link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2018-03-16/full_ifrs/full_ifrs-cor_2018-03-16.xsd#ifrs-full_AdjustmentsForDecreaseIncreaseInInventories" xlink:label="loc_ifrs-fullAdjustmentsForDecreaseIncreaseInInventories"/>

<link:calculationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-fullCashFlowsFromUsedInOperatingActivities" xlink:to="loc_ifrs-fullAdjustmentsForDecreaseIncreaseInInventories" xlink:type="arc" weight="1"/>

<link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2018-03-16/full_ifrs/full_ifrs-cor_2018-03-16.xsd#ifrs-full_AdjustmentsForIncreaseDecreaseInTradeAndOtherPayables" xlink:label="loc_ifrs-fullAdjustmentsForIncreaseDecreaseInTradeAndOtherPayables"/>

<link:calculationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-fullCashFlowsFromUsedInOperatingActivities" xlink:to="loc_ifrs-fullAdjustmentsForIncreaseDecreaseInTradeAndOtherPayables" xlink:type="arc" weight="1"/>

<link:loc xlink:type="locator" xlink:href="nymx-20181231.xsd#NYMX_IssuedStockForCommissionAndOptionExpense" xlink:label="loc_NYMXIssuedStockForCommissionAndOptionExpense"/>

<link:calculationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-fullCashFlowsFromUsedInOperatingActivities" xlink:to="loc_NYMXIssuedStockForCommissionAndOptionExpense" xlink:type="arc" weight="1"/>

<link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2018-03-16/full_ifrs/full_ifrs-cor_2018-03-16.xsd#ifrs-full_CashFlowsFromUsedInInvestingActivities" xlink:label="loc_ifrs-fullCashFlowsFromUsedInInvestingActivities"/>

<link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2018-03-16/full_ifrs/full_ifrs-cor_2018-03-16.xsd#ifrs-full_PurchaseOfPropertyPlantAndEquipmentClassifiedAsInvestingActivities" xlink:label="loc_ifrs-fullPurchaseOfPropertyPlantAndEquipmentClassifiedAsInvestingActivities"/>

<link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-fullCashFlowsFromUsedInInvestingActivities" xlink:to="loc_ifrs-fullPurchaseOfPropertyPlantAndEquipmentClassifiedAsInvestingActivities" xlink:type="arc" weight="-1"/>

<link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2018-03-16/full_ifrs/full_ifrs-cor_2018-03-16.xsd#ifrs-full_CashFlowsFromUsedInFinancingActivities" xlink:label="loc_ifrs-fullCashFlowsFromUsedInFinancingActivities"/>

<link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2018-03-16/full_ifrs/full_ifrs-cor_2018-03-16.xsd#ifrs-full_ProceedsFromIssuingShares" xlink:label="loc_ifrs-fullProceedsFromIssuingShares"/>

<link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-fullCashFlowsFromUsedInFinancingActivities" xlink:to="loc_ifrs-fullProceedsFromIssuingShares" xlink:type="arc" weight="1"/>

<link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2018-03-16/full_ifrs/full_ifrs-cor_2018-03-16.xsd#ifrs-full_IncreaseDecreaseInCashAndCashEquivalents" xlink:label="loc_ifrs-fullIncreaseDecreaseInCashAndCashEquivalents"/>

<link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-fullIncreaseDecreaseInCashAndCashEquivalents" xlink:to="loc_ifrs-fullCashFlowsFromUsedInOperatingActivities" xlink:type="arc" weight="1"/>

<link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-fullIncreaseDecreaseInCashAndCashEquivalents" xlink:to="loc_ifrs-fullCashFlowsFromUsedInFinancingActivities" xlink:type="arc" weight="1"/>

<link:calculationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-fullIncreaseDecreaseInCashAndCashEquivalents" xlink:to="loc_ifrs-fullCashFlowsFromUsedInInvestingActivities" xlink:type="arc" weight="1"/>

</link:calculationLink>

<link:calculationLink xlink:type="extended" xlink:role="http://nymox.com/role/BusinessActivitiesAndBasisOfPresentation" xlink:title="00000007 - Disclosure - BUSINESS ACTIVITIES AND BASIS OF PRESENTATION"/>

<link:calculationLink xlink:type="extended" xlink:role="http://nymox.com/role/GoingConcernConsiderations" xlink:title="00000008 - Disclosure - GOING CONCERN CONSIDERATIONS"/>

<link:calculationLink xlink:type="extended" xlink:role="http://nymox.com/role/SignificantEstimates" xlink:title="00000009 - Disclosure - SIGNIFICANT ESTIMATES"/>

<link:calculationLink xlink:type="extended" xlink:role="http://nymox.com/role/SignificantAccountingPolicies" xlink:title="00000010 - Disclosure - SIGNIFICANT ACCOUNTING POLICIES"/>

<link:calculationLink xlink:type="extended" xlink:role="http://nymox.com/role/NewAccountingStandardsAndInterpretations" xlink:title="00000011 - Disclosure - NEW ACCOUNTING STANDARDS AND INTERPRETATIONS"/>

<link:calculationLink xlink:type="extended" xlink:role="http://nymox.com/role/PropertyAndEquipment" xlink:title="00000012 - Disclosure - PROPERTY AND EQUIPMENT"/>

<link:calculationLink xlink:type="extended" xlink:role="http://nymox.com/role/IntangibleAssets" xlink:title="00000013 - Disclosure - INTANGIBLE ASSETS"/>

<link:calculationLink xlink:type="extended" xlink:role="http://nymox.com/role/AccountsPayableAndAccruedLiabilities" xlink:title="00000014 - Disclosure - ACCOUNTS PAYABLE AND ACCRUED LIABILITIES"/>

<link:calculationLink xlink:type="extended" xlink:role="http://nymox.com/role/ConvertibleNotes" xlink:title="00000015 - Disclosure - CONVERTIBLE NOTES"/>

<link:calculationLink xlink:type="extended" xlink:role="http://nymox.com/role/CommitmentsAndContingencies" xlink:title="00000016 - Disclosure - COMMITMENTS AND CONTINGENCIES"/>

<link:calculationLink xlink:type="extended" xlink:role="http://nymox.com/role/ShareCapital" xlink:title="00000017 - Disclosure - SHARE CAPITAL"/>

<link:calculationLink xlink:type="extended" xlink:role="http://nymox.com/role/StockOptions" xlink:title="00000018 - Disclosure - STOCK OPTIONS"/>

<link:calculationLink xlink:type="extended" xlink:role="http://nymox.com/role/ShareBasedCompensation" xlink:title="00000019 - Disclosure - SHARE BASED COMPENSATION"/>

<link:calculationLink xlink:type="extended" xlink:role="http://nymox.com/role/Warrants" xlink:title="00000020 - Disclosure - WARRANTS"/>

<link:calculationLink xlink:type="extended" xlink:role="http://nymox.com/role/IncomeTaxes" xlink:title="00000021 - Disclosure - INCOME TAXES"/>

<link:calculationLink xlink:type="extended" xlink:role="http://nymox.com/role/EarningsPerShare" xlink:title="00000022 - Disclosure - EARNINGS PER SHARE"/>

<link:calculationLink xlink:type="extended" xlink:role="http://nymox.com/role/FinancialInstrumentsFairValueDisclosures" xlink:title="00000023 - Disclosure - FINANCIAL INSTRUMENTS FAIR VALUE DISCLOSURES"/>

<link:calculationLink xlink:type="extended" xlink:role="http://nymox.com/role/FinanceIncomeAndFinanceCosts" xlink:title="00000024 - Disclosure - FINANCE INCOME AND FINANCE COSTS"/>

<link:calculationLink xlink:type="extended" xlink:role="http://nymox.com/role/SegmentDisclosures" xlink:title="00000025 - Disclosure - SEGMENT DISCLOSURES"/>

<link:calculationLink xlink:type="extended" xlink:role="http://nymox.com/role/Concentrations" xlink:title="00000026 - Disclosure - CONCENTRATIONS"/>

<link:calculationLink xlink:type="extended" xlink:role="http://nymox.com/role/RelatedPartyTransactions" xlink:title="00000027 - Disclosure - RELATED PARTY TRANSACTIONS"/>

<link:calculationLink xlink:type="extended" xlink:role="http://nymox.com/role/ResearchAndDevelopmentExpenses" xlink:title="00000028 - Disclosure - RESEARCH AND DEVELOPMENT EXPENSES"/>

<link:calculationLink xlink:type="extended" xlink:role="http://nymox.com/role/PersonnelExpenses" xlink:title="00000029 - Disclosure - PERSONNEL EXPENSES"/>

<link:calculationLink xlink:type="extended" xlink:role="http://nymox.com/role/CapitalDisclosuresAndFinancialRisk" xlink:title="00000030 - Disclosure - CAPITAL DISCLOSURES AND FINANCIAL RISK"/>

<link:calculationLink xlink:type="extended" xlink:role="http://nymox.com/role/ForeignExchangeRisk" xlink:title="00000031 - Disclosure - FOREIGN EXCHANGE RISK"/>

<link:calculationLink xlink:type="extended" xlink:role="http://nymox.com/role/CreditRisk" xlink:title="00000032 - Disclosure - CREDIT RISK"/>

<link:calculationLink xlink:type="extended" xlink:role="http://nymox.com/role/InterestRateRisk" xlink:title="00000033 - Disclosure - 27. INTEREST RATE RISK"/>

<link:calculationLink xlink:type="extended" xlink:role="http://nymox.com/role/LiquidityRisk" xlink:title="00000034 - Disclosure - 28. LIQUIDITY RISK"/>

<link:calculationLink xlink:type="extended" xlink:role="http://nymox.com/role/SubsequentEvents" xlink:title="00000035 - Disclosure - 29. SUBSEQUENT EVENTS"/>

<link:calculationLink xlink:type="extended" xlink:role="http://nymox.com/role/SignificantAccountingPoliciesPolicies" xlink:title="00000036 - Disclosure - SIGNIFICANT ACCOUNTING POLICIES (Policies)"/>

<link:calculationLink xlink:type="extended" xlink:role="http://nymox.com/role/SignificantAccountingPoliciesTables" xlink:title="00000037 - Disclosure - SIGNIFICANT ACCOUNTING POLICIES (Tables)"/>

<link:calculationLink xlink:type="extended" xlink:role="http://nymox.com/role/PropertyAndEquipmentTables" xlink:title="00000038 - Disclosure - PROPERTY AND EQUIPMENT (Tables)"/>

<link:calculationLink xlink:type="extended" xlink:role="http://nymox.com/role/AccountsPayableAndAccruedLiabilitiesTables" xlink:title="00000039 - Disclosure - ACCOUNTS PAYABLE AND ACCRUED LIABILITIES (Tables)"/>

<link:calculationLink xlink:type="extended" xlink:role="http://nymox.com/role/ConvertibleNotesTables" xlink:title="00000040 - Disclosure - CONVERTIBLE NOTES (Tables)"/>

<link:calculationLink xlink:type="extended" xlink:role="http://nymox.com/role/CommitmentsAndContingenciesTables" xlink:title="00000041 - Disclosure - COMMITMENTS AND CONTINGENCIES (Tables)"/>

<link:calculationLink xlink:type="extended" xlink:role="http://nymox.com/role/ShareCapitalTables" xlink:title="00000042 - Disclosure - SHARE CAPITAL (Tables)"/>

<link:calculationLink xlink:type="extended" xlink:role="http://nymox.com/role/StockOptionsTables" xlink:title="00000043 - Disclosure - STOCK OPTIONS (Tables)"/>

<link:calculationLink xlink:type="extended" xlink:role="http://nymox.com/role/ShareBasedCompensationTables" xlink:title="00000044 - Disclosure - SHARE BASED COMPENSATION (Tables)"/>

<link:calculationLink xlink:type="extended" xlink:role="http://nymox.com/role/WarrantsTables" xlink:title="00000045 - Disclosure - WARRANTS (Tables)"/>

<link:calculationLink xlink:type="extended" xlink:role="http://nymox.com/role/IncomeTaxesTables" xlink:title="00000046 - Disclosure - INCOME TAXES (Tables)"/>

<link:calculationLink xlink:type="extended" xlink:role="http://nymox.com/role/EarningsPerShareTables" xlink:title="00000047 - Disclosure - EARNINGS PER SHARE (Tables)"/>

<link:calculationLink xlink:type="extended" xlink:role="http://nymox.com/role/FinanceIncomeAndFinanceCostsTables" xlink:title="00000048 - Disclosure - FINANCE INCOME AND FINANCE COSTS (Tables)"/>

<link:calculationLink xlink:type="extended" xlink:role="http://nymox.com/role/SegmentDisclosuresTables" xlink:title="00000049 - Disclosure - SEGMENT DISCLOSURES (Tables)"/>

<link:calculationLink xlink:type="extended" xlink:role="http://nymox.com/role/ConcentrationsTables" xlink:title="00000050 - Disclosure - CONCENTRATIONS (Tables)"/>

<link:calculationLink xlink:type="extended" xlink:role="http://nymox.com/role/RelatedPartyTransactionsTables" xlink:title="00000051 - Disclosure - RELATED PARTY TRANSACTIONS (Tables)"/>

<link:calculationLink xlink:type="extended" xlink:role="http://nymox.com/role/ResearchAndDevelopmentExpensesTables" xlink:title="00000052 - Disclosure - RESEARCH AND DEVELOPMENT EXPENSES (Tables)"/>

<link:calculationLink xlink:type="extended" xlink:role="http://nymox.com/role/PersonnelExpensesTables" xlink:title="00000053 - Disclosure - PERSONNEL EXPENSES (Tables)"/>

<link:calculationLink xlink:type="extended" xlink:role="http://nymox.com/role/LiquidityRiskTables" xlink:title="00000054 - Disclosure - Liquidity risk (Tables)"/>

<link:calculationLink xlink:type="extended" xlink:role="http://nymox.com/role/SignificantAccountingPoliciesDetails" xlink:title="00000055 - Disclosure - SIGNIFICANT ACCOUNTING POLICIES (Details)"/>

<link:calculationLink xlink:type="extended" xlink:role="http://nymox.com/role/NewAccountingStandardsAndInterpretations" xlink:title="00000056 - Disclosure - NEW ACCOUNTING STANDARDS AND INTERPRETATIONS"/>

<link:calculationLink xlink:type="extended" xlink:role="http://nymox.com/role/PropertyAndEquipmentDetails" xlink:title="00000057 - Disclosure - PROPERTY AND EQUIPMENT (Details)"/>

<link:calculationLink xlink:type="extended" xlink:role="http://nymox.com/role/PropertyAndEquipmentDetailsNarrative" xlink:title="00000058 - Disclosure - PROPERTY AND EQUIPMENT (Details Narrative)"/>

<link:calculationLink xlink:type="extended" xlink:role="http://nymox.com/role/IntangibleAssetsDetailsNarrative" xlink:title="00000059 - Disclosure - INTANGIBLE ASSETS (Details Narrative)"/>

<link:calculationLink xlink:type="extended" xlink:role="http://nymox.com/role/AccountsPayableAndAccruedLiabilitiesDetails" xlink:title="00000060 - Disclosure - ACCOUNTS PAYABLE AND ACCRUED LIABILITIES (Details)"/>

<link:calculationLink xlink:type="extended" xlink:role="http://nymox.com/role/ConvertibleNotesDetails" xlink:title="00000061 - Disclosure - CONVERTIBLE NOTES (Details)"/>

<link:calculationLink xlink:type="extended" xlink:role="http://nymox.com/role/ConvertibleNotesDetailsNarrative" xlink:title="00000062 - Disclosure - CONVERTIBLE NOTES (Details Narrative)"/>

<link:calculationLink xlink:type="extended" xlink:role="http://nymox.com/role/CommitmentsAndContingenciesDetails" xlink:title="00000063 - Disclosure - COMMITMENTS AND CONTINGENCIES (Details)"/>

<link:calculationLink xlink:type="extended" xlink:role="http://nymox.com/role/CommitmentsAndContingenciesDetails1" xlink:title="00000064 - Disclosure - COMMITMENTS AND CONTINGENCIES (Details 1)"/>

<link:calculationLink xlink:type="extended" xlink:role="http://nymox.com/role/CommitmentsAndContingenciesDetails2" xlink:title="00000065 - Disclosure - COMMITMENTS AND CONTINGENCIES (Details 2)"/>

<link:calculationLink xlink:type="extended" xlink:role="http://nymox.com/role/CommitmentsAndContingenciesDetailsNarrative" xlink:title="00000066 - Disclosure - COMMITMENTS AND CONTINGENCIES (Details Narrative)"/>

<link:calculationLink xlink:type="extended" xlink:role="http://nymox.com/role/ShareCapitalDetails" xlink:title="00000067 - Disclosure - SHARE CAPITAL (Details)"/>

<link:calculationLink xlink:type="extended" xlink:role="http://nymox.com/role/ShareCapitalDetailsNarrative" xlink:title="00000068 - Disclosure - SHARE CAPITAL (Details Narrative)"/>

<link:calculationLink xlink:type="extended" xlink:role="http://nymox.com/role/StockOptionsDetails" xlink:title="00000069 - Disclosure - STOCK OPTIONS (Details)"/>

<link:calculationLink xlink:type="extended" xlink:role="http://nymox.com/role/StockOptionsDetails1" xlink:title="00000070 - Disclosure - STOCK OPTIONS (Details 1)"/>

<link:calculationLink xlink:type="extended" xlink:role="http://nymox.com/role/StockOptionsDetailsNarrative" xlink:title="00000071 - Disclosure - STOCK OPTIONS (Details Narrative)"/>

<link:calculationLink xlink:type="extended" xlink:role="http://nymox.com/role/ShareBasedCompensationDetails" xlink:title="00000072 - Disclosure - SHARE BASED COMPENSATION (Details)"/>

<link:calculationLink xlink:type="extended" xlink:role="http://nymox.com/role/ShareBasedCompensationDetailsNarrative" xlink:title="00000073 - Disclosure - SHARE BASED COMPENSATION (Details Narrative)"/>

<link:calculationLink xlink:type="extended" xlink:role="http://nymox.com/role/WarrantsDetails" xlink:title="00000074 - Disclosure - WARRANTS (Details)"/>

<link:calculationLink xlink:type="extended" xlink:role="http://nymox.com/role/WarrantsDetailsNarrative" xlink:title="00000075 - Disclosure - WARRANTS (Details Narrative)"/>

<link:calculationLink xlink:type="extended" xlink:role="http://nymox.com/role/IncomeTaxesDetails" xlink:title="00000076 - Disclosure - INCOME TAXES (Details)"/>

<link:calculationLink xlink:type="extended" xlink:role="http://nymox.com/role/IncomeTaxesDetails1" xlink:title="00000077 - Disclosure - INCOME TAXES (Details 1)"/>

<link:calculationLink xlink:type="extended" xlink:role="http://nymox.com/role/IncomeTaxesDetails2" xlink:title="00000078 - Disclosure - INCOME TAXES (Details 2)"/>

<link:calculationLink xlink:type="extended" xlink:role="http://nymox.com/role/IncomeTaxesDetailsNarrative" xlink:title="00000079 - Disclosure - INCOME TAXES (Details Narrative)"/>

<link:calculationLink xlink:type="extended" xlink:role="http://nymox.com/role/EarningsPerShareDetails" xlink:title="00000080 - Disclosure - EARNINGS PER SHARE (Details)"/>

<link:calculationLink xlink:type="extended" xlink:role="http://nymox.com/role/FinancialInstrumentsFairValueDisclosuresDetailsNarrative" xlink:title="00000081 - Disclosure - FINANCIAL INSTRUMENTS FAIR VALUE DISCLOSURES (Details Narrative)"/>

<link:calculationLink xlink:type="extended" xlink:role="http://nymox.com/role/FinanceIncomeAndFinanceCostsDetails" xlink:title="00000082 - Disclosure - FINANCE INCOME AND FINANCE COSTS (Details)"/>

<link:calculationLink xlink:type="extended" xlink:role="http://nymox.com/role/SegmentDisclosuresDetails" xlink:title="00000083 - Disclosure - SEGMENT DISCLOSURES (Details)"/>

<link:calculationLink xlink:type="extended" xlink:role="http://nymox.com/role/ConcentrationsDetails" xlink:title="00000084 - Disclosure - CONCENTRATIONS (Details)"/>

<link:calculationLink xlink:type="extended" xlink:role="http://nymox.com/role/RelatedPartyTransactionsDetails" xlink:title="00000085 - Disclosure - RELATED PARTY TRANSACTIONS (Details)"/>

<link:calculationLink xlink:type="extended" xlink:role="http://nymox.com/role/RelatedPartyTransactionsDetailsNarrative" xlink:title="00000086 - Disclosure - RELATED PARTY TRANSACTIONS (Details Narrative)"/>

<link:calculationLink xlink:type="extended" xlink:role="http://nymox.com/role/ResearchAndDevelopmentExpensesDetails" xlink:title="00000087 - Disclosure - RESEARCH AND DEVELOPMENT EXPENSES (Details)"/>

<link:calculationLink xlink:type="extended" xlink:role="http://nymox.com/role/PersonnelExpensesDetails" xlink:title="00000088 - Disclosure - PERSONNEL EXPENSES (Details)"/>

<link:calculationLink xlink:type="extended" xlink:role="http://nymox.com/role/CapitalDisclosuresAndFinancialRiskDetailsNarrative" xlink:title="00000089 - Disclosure - CAPITAL DISCLOSURES AND FINANCIAL RISK (Details Narrative)"/>

<link:calculationLink xlink:type="extended" xlink:role="http://nymox.com/role/ForeignExchangeRiskDetailsNarrative" xlink:title="00000090 - Disclosure - Foreign Exchange risk (Details Narrative)"/>

<link:calculationLink xlink:type="extended" xlink:role="http://nymox.com/role/CreditRiskDetailsNarrative" xlink:title="00000091 - Disclosure - Credit risk (Details Narrative)"/>

<link:calculationLink xlink:type="extended" xlink:role="http://nymox.com/role/InterestRateRiskDetailsNarrative" xlink:title="00000092 - Disclosure - Interest rate risk (Details Narrative)"/>

<link:calculationLink xlink:type="extended" xlink:role="http://nymox.com/role/LiquidityRiskDetails" xlink:title="00000093 - Disclosure - Liquidity risk (Details)"/>

<link:calculationLink xlink:type="extended" xlink:role="http://nymox.com/role/SubsequentEventsDetailsNarrative" xlink:title="00000094 - Disclosure - SUBSEQUENT EVENTS (Details Narrative)"/>

</link:linkbase>

↑Top

Filing Submission 0001640334-19-000464 – Alternative Formats (Word / Rich Text, HTML, Plain Text, et al.)

Nymox Pharmaceutical Corp – ‘20-F’ for 12/31/18 – ‘EX-101.CAL’

On: Friday, 3/29/19, at 5:20pm ET · For: 12/31/18 · Accession #: 1640334-19-464 · File #: 1-12033

Previous ‘20-F’: ‘20-F/A’ on 5/11/18 for 12/31/17 · Next: ‘20-F’ on 3/30/20 for 12/31/19 · Latest: ‘20-F’ on 5/2/23 for 12/31/22

Annual Report by a Foreign Non-Canadian Issuer — Form 20-F — Sect. 13 / 15(d) – SEA’34Filing Table of Contents

‘EX-101.CAL’ — XBRL Calculations — nymx-20181231_cal

This Exhibit is an XBRL XML File.

Annual Report by a Foreign Non-Canadian Issuer — Form 20-F — Sect. 13 / 15(d) – SEA’34
Filing Table of Contents